| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,340,000,000 |
| Market
Cap: |
111.92(B) |
| Last
Volume: |
23,255,346 |
Avg
Vol: |
0 |
| 52
Week Range: |
$69.43 - $90.4 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 125 |
| Guru Rank Value : 7.5 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Medtronic is a medical technology, services and solutions company. Co.'s four operating and reportable segments are as follows: Cardiovascular Portfolio, which is made up of the cardiac rhythm and heart failure, structural heart and aortic, and coronary and peripheral vascular divisions; Medical Surgical Portfolio, which is made up of the surgical innovations and respiratory, gastrointestinal, and renal divisions; Neuroscience Portfolio is made up of the cranial and spinal technologies, specialty therapies, and neuromodulation divisions; and Diabetes Operating Unit, which develops, manufactures, and markets products and services for the management of Type 1 and Type 2 diabetes.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
31,549 |
36,546 |
56,412 |
75,447 |
| Total Sell Value |
$2,684,057 |
$3,094,660 |
$4,783,517 |
$6,318,268 |
| Total People Sold |
2 |
3 |
5 |
5 |
| Total Sell Transactions |
2 |
3 |
8 |
10 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kuntz Richard |
SVP & Chief Medical & Science |
• • – |
2019-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
10,330 |
110,755 |
|
- |
|
| Lerman Bradley E |
SVP General Counsel & Corp Sec |
• • – |
2019-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
10,330 |
69,038 |
|
- |
|
| Coyle Michael J |
EVP & Group Pres, Cardiac&Vasc |
• • – |
2019-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
14,850 |
217,708 |
|
- |
|
| White Robert John |
EVP & President MITG |
• • – |
2019-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
11,622 |
60,099 |
|
- |
|
| Liddicoat John R |
EVP & President of Americas |
• • – |
2019-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
6,134 |
49,053 |
|
- |
|
| Parkhill Karen L |
EVP & Chief Financial Officer |
• • – |
2019-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
14,204 |
90,925 |
|
- |
|
| Martha Geoffrey |
EVP & GroupPres Restora Therap |
• • – |
2019-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
12,267 |
61,412 |
|
- |
|
| Ten Hoedt Rob |
EVP & President EMEA |
• • – |
2019-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
9,039 |
68,039 |
|
- |
|
| Surface Carol A |
SVP, Chief HR Officer |
• • – |
2019-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
7,425 |
41,771 |
|
- |
|
| Kuntz Richard |
SVP & Chief Medical & Science |
• • – |
2019-07-22 |
4 |
AS |
$101.12 |
$347,651 |
D/D |
(3,438) |
100,127 |
|
- |
|
| Parkhill Karen L |
EVP & Chief Financial Officer |
• • – |
2019-06-21 |
4 |
GA |
$0.00 |
$0 |
I/I |
900 |
300 |
|
- |
|
| Parkhill Karen L |
EVP & Chief Financial Officer |
• • – |
2019-06-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
900 |
76,507 |
|
- |
|
| Parkhill Karen L |
EVP & Chief Financial Officer |
• • – |
2019-06-20 |
4 |
D |
$99.26 |
$689,361 |
D/D |
(6,945) |
77,407 |
|
- |
|
| Surface Carol A |
SVP, Chief HR Officer |
• • – |
2019-06-17 |
4 |
S |
$97.66 |
$878,976 |
D/D |
(9,000) |
34,158 |
|
- |
|
| Hakami Hooman |
EVP & Group President Diabetes |
• • – |
2019-06-12 |
4 |
AS |
$97.49 |
$5,134,213 |
D/D |
(52,664) |
42,673 |
|
- |
|
| Hakami Hooman |
EVP & Group President Diabetes |
• • – |
2019-06-12 |
4 |
OE |
$78.00 |
$2,475,018 |
D/D |
31,731 |
95,337 |
|
- |
|
| Martha Geoffrey |
EVP & GroupPres Restora Therap |
• • – |
2019-06-06 |
4 |
S |
$96.05 |
$1,056,583 |
D/D |
(11,000) |
48,918 |
|
- |
|
| Ten Hoedt Rob |
EVP & President EMEA |
• • – |
2019-05-28 |
4 |
S |
$91.88 |
$826,920 |
D/D |
(9,000) |
58,785 |
|
- |
|
| Anderson Richard H |
Director |
• • – |
2019-05-24 |
4 |
B |
$92.40 |
$1,007,160 |
D/D |
10,900 |
89,912 |
2.39 |
- |
|
| Craig Arnold |
Director |
• • – |
2019-04-30 |
4 |
D |
$88.81 |
$38,099 |
D/D |
(429) |
30,624 |
|
- |
|
| Nabel Elizabeth G |
Director |
• • – |
2019-04-30 |
4 |
D |
$88.81 |
$38,099 |
D/D |
(429) |
8,023 |
|
- |
|
| Powell Kendall J |
Director |
• • – |
2019-04-30 |
4 |
D |
$88.81 |
$47,691 |
D/D |
(537) |
32,247 |
|
- |
|
| Lenehan James T |
Director |
• • – |
2019-04-30 |
4 |
D |
$88.81 |
$38,099 |
D/D |
(429) |
53,522 |
|
- |
|
| Hogan Randall J |
Director |
• • – |
2019-04-30 |
4 |
D |
$88.81 |
$38,099 |
D/D |
(429) |
37,150 |
|
- |
|
| Donnelly Scott C |
Director |
• • – |
2019-04-30 |
4 |
D |
$88.81 |
$38,099 |
D/D |
(429) |
10,930 |
|
- |
|
680 Records found
|
|
Page 14 of 28 |
|
|
0.68 (0.82%) 
